{"database": "openregs", "table": "documents", "rows": [["FDA-2026-N-0707-0001", "FDA", "FDA-2026-N-0707", "GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (Leucovorin Calcium) Tablets, EQ 5 mg Base and EQ 25 mg Base", "Notice", "Withdrawal", "2026-04-10T04:00:00Z", 2026, 4, "2026-04-10T04:00:00Z", null, "2026-04-10T17:40:29Z", "2026-06911", 0, 0, "09000064b926837d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-0707-0001"], "units": {}, "query_ms": 0.48000295646488667, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}